MARATTO

article · Quantum Journal of Medical and Health Sciences

HISTOPATHOLOGICAL EVALUATION OF PHYLLANTHUS MUELLERIANUS ROOT EXTRACTS: PROTECTIVE EFFECTS ON TISSUES IN LETROZOLE-INDUCED RATS

Abstract

The histopathological evaluation of kidney, liver, and heart tissues was conducted to investigate the protective and toxicological effects of aqueous and ethanolic root extracts of Phyllanthus muellerianus in rats administered letrozole (LTZ). LTZ-induced damage was characterized by hemorrhagic changes, necrosis, and inflammatory cell infiltration in the kidney, liver, and heart tissues. Treatment with 30 mg/kg body weight of both aqueous and ethanolic extracts showed marked restoration of normal histological features, particularly in the kidney and heart, with reduced cellular degeneration and inflammation. However, higher doses (60 mg/kg and 120 mg/kg) exhibited variable outcomes, including focal necrosis, hemorrhagic lesions, and inflammatory aggregates, particularly in the liver and kidney tissues. These findings highlight the dose-dependent therapeutic and toxicological effects of P. muellerianus root extracts, with lower doses demonstrating significant protective potential against LTZ-induced organ damage. The study underscores the importance of dose optimization in harnessing the therapeutic benefits of P. muellerianus while minimizing potential toxicities. Further research is recommended to elucidate the mechanisms underlying these effects and their implications for clinical application.

Research topics

  • Phytochemistry and Bioactivity Studies
  • Nigella sativa pharmacological applications
  • Phytochemistry and biological activity of medicinal plants

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.55197/qjmhs.v4i2.130

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.